Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G1–S Phase Progression in Human Glioblastoma Stem Cells
Authors:
- Federica Maddalena RacitiFRFederica Maddalena Raciti
- Valentina CarliniVCValentina Carlini
- Ivan VerduciIVIvan Verduci
- Sarah SerticSSSarah Sertic
- Sara BarozziSBSara Barozzi
- Massimiliano GarréMGMassimiliano Garré
- Antonio DagaADAntonio Daga
- Federica BarbieriFBFederica Barbieri
- Alex CostaACAlex Costa
- Tullio FlorioTFTullio Florio
Open Access
- 1 November 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 17 (11) , 2451-2461
Abstract
Glioblastoma (GB) is the most lethal, aggressive, and diffuse brain tumor. The main challenge for successful treatment is targeting the cancer stem cell (CSC) subpopulation responsible for tumor origin, progression, and recurrence. Chloride Intracellular Channel 1 (CLIC1), highly expressed in CSCs, is constitutively present in the plasma membrane where it is associated with chloride ion permeability. In vitro, CLIC1 inhibition leads to a significant arrest of GB CSCs in G1 phase of the cell cycle. Furthermore, CLIC1 knockdown impairs tumor growth in vivo. Here, we demonstrate that CLIC1 membrane localization and function is specific for GB CSCs. Mesenchymal stem cells (MSC) do not show CLIC1-associated chloride permeability, and inhibition of CLIC1 protein function has no influence on MSC cell-cycle progression. Investigation of the basic functions of GB CSCs reveals a constitutive state of oxidative stress and cytoplasmic alkalinization compared with MSCs. Both intracellular oxidation and cytoplasmic pH changes have been reported to affect CLIC1 membrane functional expression. We now report that in CSCs these three elements are temporally linked during CSC G1–S transition. Impeding CLIC1-mediated chloride current prevents both intracellular ROS accumulation and pH changes. CLIC1 membrane functional impairment results in GB CSCs resetting from an allostatic tumorigenic condition to a homeostatic steady state. In contrast, inhibiting NADPH oxidase and NHE1 proton pump results in cell death of both GB CSCs and MSCs. Our results show that CLIC1 membrane protein is crucial and specific for GB CSC proliferation, and is a promising pharmacologic target for successful brain tumor therapies. Mol Cancer Ther; 17(11); 2451–61. ©2018 AACR.Keywords
All Related Versions
Funding Information
- Italian Association for Cancer Research (AIRC), Italy (16713, IG 2015)
This publication has 46 references indexed in Scilit:
- Functional Role of CLIC1 Ion Channel in Glioblastoma-Derived Stem/Progenitor CellsJNCI: Journal of the National Cancer Institute, 2013
- Point Mutations in the Transmembrane Region of the Clic1 Ion Channel Selectively Modify Its Biophysical PropertiesPLOS ONE, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Tumor cell metabolismCancer Biology & Therapy, 2011
- NADPH Oxidase Subunit 4-Mediated Reactive Oxygen Species Contribute to Cycling Hypoxia-Promoted Tumor Progression in Glioblastoma MultiformePLOS ONE, 2011
- HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangersJournal of Cell Science, 2010
- The enigma of the CLIC proteins: Ion channels, redox proteins, enzymes, scaffolding proteins?FEBS Letters, 2010
- Redox Control of the Cell Cycle in Health and DiseaseAntioxidants & Redox Signaling, 2009
- Structural Dynamics of Soluble Chloride Intracellular Channel Protein CLIC1 Examined by Amide Hydrogen−Deuterium Exchange Mass SpectrometryBiochemistry, 2009
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase InhibitorsJournal of Biological Chemistry, 2009